Who is sponsoring NCT01967017?

NCT01967017 is sponsored by Johns Hopkins University.

What condition does NCT01967017 study?

NCT01967017 studies IUD Insertion Complication, Pain Control.

What drugs are being tested in NCT01967017?

Interventions: Lidocaine, Placebo.

What is the status of NCT01967017?

NCT01967017 is currently WITHDRAWN.

Last reviewed 2017-06-09 · How we verify

Paracervical Block With Lidocaine as a Modality to Decrease IUD Insertion Related Pain

NCT01967017 Phase 4 WITHDRAWN

Despite the high efficacy of intrauterine devices (IUDs), some women choose not to receive IUDs secondary to the pain associated with insertion. Nulliparous women may be especially susceptible to procedure-related pain from IUD insertion. This study will investigate the difference in perceived pain from IUD insertion, comparing local anesthesia to a placebo, among women who have not had a vaginal delivery before. The investigators anticipate that among women who have not had a previous vaginal delivery, the pain associated with IUD insertion will be significantly decreased after administration of local anesthesia.

Details

Lead sponsor	Johns Hopkins University
Phase	Phase 4
Status	WITHDRAWN
Start date	2014-06
Completion	2014-06

Conditions

IUD Insertion Complication
Pain Control

Interventions

Lidocaine
Placebo

Primary outcomes

Pain at time of IUD insertion — During IUD insertion (no further follow up after patient leaves ofice)
Differences in visual analog scale (VAS) measurements of perceived pain at the time of IUD deployment

Countries

United States